Amin U. Haq, MD; Jonathan Glass, MD; Catherine V. Netchvolodoff, MD; L. Michael Bowen, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is characterized by recurrent bleeding episodes, multiple telangiectasias, and familial occurrence. Treatment of this disease is unsatisfactory. Oral estrogen may be very useful in controlling the frequency and severity of epistaxis (1). However, due to the feminizing effects of estrogens, male patients may be reluctant to take the hormones. The authors were recently forced to search for an alternative treatment in a male patient who refused to take estrogen. There was marked improvement of symptoms with danazol, a synthetic weak androgen.
A 41-year-old white army veteran had severe anemia; he had a
Haq AU, Glass J, Netchvolodoff CV, et al. Hereditary Hemorrhagic Telangiectasia and Danazol. Ann Intern Med. 1988;109:171. doi: 10.7326/0003-4819-109-2-171_1
Download citation file:
Published: Ann Intern Med. 1988;109(2):171.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use